Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-11 to 2023-06-02
Current total value of award: $36541.48
Description: 4560923386!HEMLIBRA 150 MG/ML VIALML